-
Je něco špatně v tomto záznamu ?
Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water
N. Abramenko, Z. Kejík, R. Kaplánek, A. Tatar, T. Brogyányi, M. Pajková, D. Sýkora, K. Veselá, V. Antonyová, P. Dytrych, M. Ikeda-Saito, P. Martásek, M. Jakubek
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
32854159
DOI
10.1111/cbdd.13782
Knihovny.cz E-zdroje
- MeSH
- inhibitory protonové pumpy chemie MeSH
- komplexní sloučeniny chemie MeSH
- lanzoprazol * chemie MeSH
- omeprazol chemie MeSH
- pantoprazol chemie MeSH
- přechodné kovy chemie MeSH
- spektrofotometrie * MeSH
- voda chemie MeSH
- železité sloučeniny chemie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Proton pump inhibitors, such as omeprazole, pantoprazole and lansoprazole, are an important group of clinically used drugs. Generally, they are considered safe without direct toxicity. Nevertheless, their long-term use can be associated with a higher risk of some serious pathological states (e.g. amnesia and oncological and neurodegenerative states). It is well known that dysregulation of the metabolism of transition metals (especially iron ions) plays a significant role in these pathological states and that the above drugs can form complexes with metal ions. However, to the best of our knowledge, this phenomenon has not yet been described in water systems. Therefore, we studied the interaction between these drugs and transition metal ions in the surrounding water environment (water/DMSO, 99:1, v/v) by absorption spectroscopy. In the presence of Fe(III), a strong redshift was observed, and more importantly, the affinities of the drugs (represented as binding constants) were strong enough, especially in the case of omeprazole, so that the formation of a metallocomplex cannot be excluded during the explanation of their side effects.
BIOCEV 1st Faculty of Medicine Charles University Vestec Czech Republic
General University Hospital Prague Prague 2 Czech Republic
Institute of Multidisciplinary Research for Advanced Materials Tohoku University Katahira Japan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026103
- 003
- CZ-PrNML
- 005
- 20211026133216.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cbdd.13782 $2 doi
- 035 __
- $a (PubMed)32854159
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Abramenko, Nikita $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 245 10
- $a Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water / $c N. Abramenko, Z. Kejík, R. Kaplánek, A. Tatar, T. Brogyányi, M. Pajková, D. Sýkora, K. Veselá, V. Antonyová, P. Dytrych, M. Ikeda-Saito, P. Martásek, M. Jakubek
- 520 9_
- $a Proton pump inhibitors, such as omeprazole, pantoprazole and lansoprazole, are an important group of clinically used drugs. Generally, they are considered safe without direct toxicity. Nevertheless, their long-term use can be associated with a higher risk of some serious pathological states (e.g. amnesia and oncological and neurodegenerative states). It is well known that dysregulation of the metabolism of transition metals (especially iron ions) plays a significant role in these pathological states and that the above drugs can form complexes with metal ions. However, to the best of our knowledge, this phenomenon has not yet been described in water systems. Therefore, we studied the interaction between these drugs and transition metal ions in the surrounding water environment (water/DMSO, 99:1, v/v) by absorption spectroscopy. In the presence of Fe(III), a strong redshift was observed, and more importantly, the affinities of the drugs (represented as binding constants) were strong enough, especially in the case of omeprazole, so that the formation of a metallocomplex cannot be excluded during the explanation of their side effects.
- 650 _2
- $a komplexní sloučeniny $x chemie $7 D056831
- 650 _2
- $a železité sloučeniny $x chemie $7 D005290
- 650 12
- $a lanzoprazol $x chemie $7 D064747
- 650 _2
- $a omeprazol $x chemie $7 D009853
- 650 _2
- $a pantoprazol $x chemie $7 D000077402
- 650 _2
- $a inhibitory protonové pumpy $x chemie $7 D054328
- 650 12
- $a spektrofotometrie $7 D013053
- 650 _2
- $a přechodné kovy $x chemie $7 D028561
- 650 _2
- $a voda $x chemie $7 D014867
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kejík, Zdeněk $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic
- 700 1_
- $a Kaplánek, Robert $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic
- 700 1_
- $a Tatar, Ameneh $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic
- 700 1_
- $a Brogyányi, Tereza $u Institute of pathological physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Pajková, Martina $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
- 700 1_
- $a Sýkora, David $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic
- 700 1_
- $a Veselá, Kateřina $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic
- 700 1_
- $a Antonyová, Veronika $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
- 700 1_
- $a Dytrych, Petr $u 1st Department of Surgery - Department of Abdominal, Thoracic Surgery and Traumatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, Czech Republic
- 700 1_
- $a Ikeda-Saito, Masao $u Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Katahira, Japan
- 700 1_
- $a Martásek, Pavel $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u General University Hospital Prague, Prague 2, Czech Republic
- 700 1_
- $a Jakubek, Milan $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic
- 773 0_
- $w MED00173265 $t Chemical biology & drug design $x 1747-0285 $g Roč. 97, č. 2 (2021), s. 305-314
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32854159 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133222 $b ABA008
- 999 __
- $a ok $b bmc $g 1714960 $s 1146610
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 97 $c 2 $d 305-314 $e 20200907 $i 1747-0285 $m Chemical biology & drug design $n Chem Biol Drug Des $x MED00173265
- LZP __
- $a Pubmed-20211013